Macleods Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is PALIPERIDONE USP, with a corresponding US DMF Number 35245.
Remarkably, this DMF maintains an Active status since its submission on April 12, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of October 31, 2023, and payment made on September 25, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II